Literature DB >> 24053487

Nod-like receptors in head and neck squamous cell carcinoma.

Camilla Rydberg Millrud1, Anne Månsson Kvarnhammar, Janos Tajti, Eva Munck-Wikland, Rolf Uddman, Lars Olaf Cardell.   

Abstract

CONCLUSION: The capability of Nod1 to recognize bacteria along with its altered expression and ability to cause an immunological response in head and neck cancer suggest a novel pathway for bacteria to interfere with ongoing cancer inflammation.
OBJECTIVE: Nucleotide oligomerization domain (Nod)-like receptors (NLRs) comprise a recently discovered family of pattern-recognition receptors. In addition to their protective function against infections, accumulating evidence suggests a role for these receptors in various diseases, including cancer. The present study was designed to explore the presence of NLRs in head and neck squamous cell carcinoma, and to determine if these cells have the ability to respond immunologically to ligand stimulation.
METHODS: The pharyngeal squamous cell carcinoma cell lines Detroit-562 and FaDu were used as a model for head and neck cancer, and compared to healthy primary human nasal epithelial cells. Analyses were performed using immunohistochemistry, real-time RT-PCR, Luminex Multiplex Immunoassay, ELISA, and flow cytometry.
RESULTS: The expression profile of NLRs in head and neck cancer cells differed from that seen in healthy epithelial cells. Further, Nod1 stimulation induced an immunological response in tumor cells that differed from the response in normal epithelial cells, especially regarding the expression of β-defensin 2, granulocyte monocyte colony stimulating factor (GM-CSF), granulocyte colony stimulating factor (G-CSF), intercellular adhesion molecule-1 (ICAM-1), and cell survival.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24053487     DOI: 10.3109/00016489.2013.831476

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  7 in total

Review 1.  Targeting innate sensing in the tumor microenvironment to improve immunotherapy.

Authors:  Zhida Liu; Chuanhui Han; Yang-Xin Fu
Journal:  Cell Mol Immunol       Date:  2019-12-16       Impact factor: 11.530

2.  Rapid nodal staging of head and neck cancer surgical specimens with flow cytometric analysis.

Authors:  Valtteri Häyry; Åsa Kågedal; Eric Hjalmarsson; Pedro Farrajota Neves da Silva; Cecilia Drakskog; Gregori Margolin; Susanna Kumlien Georén; Eva Munck-Wikland; Ola Winqvist; Lars Olaf Cardell
Journal:  Br J Cancer       Date:  2017-11-23       Impact factor: 7.640

3.  IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway.

Authors:  Leong-Perng Chan; Ling-Feng Wang; Feng-Yu Chiang; Ka-Wo Lee; Po-Lin Kuo; Chia-Hua Liang
Journal:  Oncotarget       Date:  2016-09-20

Review 4.  Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy.

Authors:  Sanja Nabergoj; Irena Mlinarič-Raščan; Žiga Jakopin
Journal:  Med Res Rev       Date:  2018-12-13       Impact factor: 12.944

5.  Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer.

Authors:  Yuanyuan Zhang; Ning Li; Guangwen Yuan; Hongwen Yao; Die Zhang; Nan Li; Gongyi Zhang; Yangchun Sun; Wenpeng Wang; Jia Zeng; Ningzhi Xu; Mei Liu; Lingying Wu
Journal:  BMC Med       Date:  2022-02-08       Impact factor: 8.775

Review 6.  NOD-Like Receptors: Master Regulators of Inflammation and Cancer.

Authors:  Mansi Saxena; Garabet Yeretssian
Journal:  Front Immunol       Date:  2014-07-14       Impact factor: 7.561

7.  Activation of the pattern recognition receptor NOD1 augments colon cancer metastasis.

Authors:  Henry Y Jiang; Sara Najmeh; Guy Martel; Elyse MacFadden-Murphy; Raquel Farias; Paul Savage; Arielle Leone; Lucie Roussel; Jonathan Cools-Lartigue; Stephen Gowing; Julie Berube; Betty Giannias; France Bourdeau; Carlos H F Chan; Jonathan D Spicer; Rebecca McClure; Morag Park; Simon Rousseau; Lorenzo E Ferri
Journal:  Protein Cell       Date:  2020-01-19       Impact factor: 14.870

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.